CEL-SCI CORPORATION Operating Expenses
CEL-SCI CORPORATION (CVM) reported Operating Expenses of $5.56 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-14
- CEL-SCI CORPORATION operating expenses for the quarter ending 2026-06-30 was $5.56M, a 1.25% increase year-over-year.
- CEL-SCI CORPORATION operating expenses for the quarter ending 2026-03-31 was $5.33M, a 16.70% decline year-over-year.
- CEL-SCI CORPORATION operating expenses for the quarter ending 2025-12-31 was $5.37M, a 22.12% decline year-over-year.
- CEL-SCI CORPORATION operating expenses for the quarter ending 2025-09-30 was $6.03M, a 1.42% decline year-over-year.
- CEL-SCI CORPORATION operating expenses for fiscal 2025 was $24.81M, a 5.85% decline from fiscal 2024.
- CEL-SCI CORPORATION operating expenses for fiscal 2024 was $26.35M, a 16.28% decline from fiscal 2023.
- CEL-SCI CORPORATION operating expenses for fiscal 2023 was $31.48M, a 12.72% decline from fiscal 2022.
- CEL-SCI CORPORATION operating expenses for fiscal 2022 was $36.06M, a 0.36% decline from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $5.56M 10-Q · filed 2026-08-14 | $10.88M derived: sum of 2 quarters · filed 2026-08-14 | $16.25M 10-Q · filed 2026-08-14 | $22.29M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $5.33M 10-Q · filed 2026-05-15 | $10.69M 10-Q · filed 2026-05-15 | $16.73M derived: sum of 3 quarters · filed 2026-05-15 | $22.22M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | $5.37M 10-Q · filed 2026-02-17 | $11.40M derived: sum of 2 quarters · filed 2026-02-17 | $16.89M derived: sum of 3 quarters · filed 2026-08-14 | $23.29M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-09-30 | $6.03M derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-29 | $11.52M derived: sum of 2 quarters · filed 2026-08-14 | $17.92M derived: sum of 3 quarters · filed 2026-08-14 | $24.81M 10-K · filed 2025-12-29 | ||||
| 2025-06-30 | $5.49M 10-Q · filed 2026-08-14 | $11.88M derived: sum of 2 quarters · filed 2026-08-14 | $18.78M 10-Q · filed 2026-08-14 | $24.90M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | $6.39M 10-Q · filed 2026-05-15 | $13.29M 10-Q · filed 2026-05-15 | $19.41M derived: sum of 3 quarters · filed 2026-05-15 | $26.08M derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | $6.89M 10-Q · filed 2026-02-17 | $13.01M derived: sum of 2 quarters · filed 2026-02-17 | $19.68M derived: sum of 3 quarters · filed 2026-02-17 | $26.76M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2024-09-30 | $6.12M derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-29 | $12.79M derived: sum of 2 quarters · filed 2025-12-29 | $19.87M derived: sum of 3 quarters · filed 2025-12-29 | $26.35M 10-K · filed 2025-12-29 | ||||
| 2024-06-30 | $6.67M 10-Q · filed 2025-08-14 | $13.75M derived: sum of 2 quarters · filed 2025-08-14 | $20.23M 10-Q · filed 2025-08-14 | $27.70M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $7.08M 10-Q · filed 2025-05-14 | $13.56M 10-Q · filed 2025-05-14 | $21.03M derived: sum of 3 quarters · filed 2025-05-14 | $29.21M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | $6.49M 10-Q · filed 2025-02-14 | $13.95M derived: sum of 2 quarters · filed 2025-02-14 | $22.14M derived: sum of 3 quarters · filed 2025-02-14 | $30.31M derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2023-09-30 | $7.47M derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-13 | $15.65M derived: sum of 2 quarters · filed 2025-01-13 | $23.83M derived: sum of 3 quarters · filed 2025-01-13 | $31.48M 10-K · filed 2025-01-13 | ||||
| 2023-06-30 | $8.18M 10-Q · filed 2024-08-14 | $16.36M derived: sum of 2 quarters · filed 2024-08-14 | $24.01M 10-Q · filed 2024-08-14 | $32.96M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $8.18M 10-Q · filed 2024-05-15 | $15.83M 10-Q · filed 2024-05-15 | $24.77M derived: sum of 3 quarters · filed 2024-05-15 | $33.49M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $7.65M 10-Q · filed 2024-02-14 | $16.60M derived: sum of 2 quarters · filed 2024-02-14 | $25.32M derived: sum of 3 quarters · filed 2024-02-14 | $34.87M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-09-30 | $8.95M derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-21 | $17.67M derived: sum of 2 quarters · filed 2023-12-21 | $27.22M derived: sum of 3 quarters · filed 2023-12-21 | $36.06M 10-K · filed 2023-12-21 | ||||
| 2022-06-30 | $8.72M 10-Q · filed 2023-08-10 | $18.27M derived: sum of 2 quarters · filed 2023-08-10 | $27.11M 10-Q · filed 2023-08-10 | $35.59M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | $9.55M 10-Q · filed 2023-05-12 | $18.40M 10-Q · filed 2023-05-12 | $26.87M derived: sum of 3 quarters · filed 2023-05-12 | $37.33M derived: sum of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | $8.84M 10-Q · filed 2023-02-14 | $17.32M derived: sum of 2 quarters · filed 2023-02-14 | $27.77M derived: sum of 3 quarters · filed 2023-02-14 | $36.31M derived: sum of 4 quarters · filed 2023-02-14 | ||||
| 2021-09-30 | $8.47M derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-27 | $18.93M derived: sum of 2 quarters · filed 2022-12-27 | $27.46M derived: sum of 3 quarters · filed 2022-12-27 | $36.19M 10-K · filed 2022-12-27 | ||||
| 2021-06-30 | $10.46M 10-Q · filed 2022-08-12 | $18.99M derived: sum of 2 quarters · filed 2022-08-12 | $27.72M 10-Q · filed 2022-08-12 | $36.19M derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | $8.53M 10-Q · filed 2022-05-13 | $17.26M 10-Q · filed 2022-05-13 | $25.74M derived: sum of 3 quarters · filed 2022-05-13 | $32.90M derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | $8.73M 10-Q · filed 2022-02-11 | $17.20M derived: sum of 2 quarters · filed 2022-02-11 | $24.37M derived: sum of 3 quarters · filed 2022-02-11 | $31.38M derived: sum of 4 quarters · filed 2022-02-11 | ||||
| 2020-09-30 | $8.47M derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-21 | $15.63M derived: sum of 2 quarters · filed 2021-12-21 | $22.65M derived: sum of 3 quarters · filed 2021-12-21 | $29.54M 10-K · filed 2021-12-21 | ||||
| 2020-06-30 | $7.16M 10-Q · filed 2021-08-13 | $7.11M 10-Q/A · filed 2020-08-11 | $14.18M derived: sum of 2 quarters · filed 2021-08-13 | $21.07M 10-Q · filed 2021-08-13 | $20.90M 10-Q/A · filed 2020-08-11 | $26.79M derived: sum of 4 quarters · filed 2021-08-13 | ||
| 2020-03-31 | $7.02M 10-Q · filed 2021-05-17 | $6.96M 10-Q · filed 2020-05-08 | $13.91M 10-Q · filed 2021-05-17 | $13.80M 10-Q · filed 2020-05-08 | $19.63M derived: sum of 3 quarters · filed 2021-05-17 | $24.95M derived: sum of 4 quarters · filed 2021-05-17 | ||
| 2019-12-31 | $6.89M 10-Q · filed 2021-02-12 | $6.84M 10-Q · filed 2020-02-10 | $12.61M derived: sum of 2 quarters · filed 2021-02-12 | $17.93M derived: sum of 3 quarters · filed 2021-02-12 | $22.39M derived: sum of 4 quarters · filed 2021-02-12 | |||
| 2019-09-30 | $5.72M derived: 10-K 12 month − 10-Q/A 9 month · filed 2020-12-29 | $11.04M derived: sum of 2 quarters · filed 2020-12-31 | $15.50M derived: sum of 3 quarters · filed 2020-12-31 | $20.66M 10-K · filed 2020-12-29 | ||||
| 2019-06-30 | $5.32M 10-Q/A · filed 2020-12-31 | $9.78M derived: sum of 2 quarters · filed 2020-12-31 | $14.94M 10-Q/A · filed 2020-12-31 | $18.65M derived: sum of 4 quarters · filed 2020-12-31 | ||||
| 2019-03-31 | $4.46M 10-Q/A · filed 2020-12-30 | $9.62M 10-Q/A · filed 2020-12-30 | $13.33M derived: sum of 3 quarters · filed 2020-12-30 | $17.50M derived: sum of 4 quarters · filed 2020-12-30 | ||||
| 2018-12-31 | $5.16M 10-Q/A · filed 2020-12-30 | $8.87M derived: sum of 2 quarters · filed 2020-12-30 | $13.05M derived: sum of 3 quarters · filed 2020-12-30 | $17.38M derived: sum of 4 quarters · filed 2020-12-30 | ||||
| 2018-09-30 | $3.71M derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-12-23 | $7.89M derived: sum of 2 quarters · filed 2019-12-23 | $12.22M derived: sum of 3 quarters · filed 2019-12-23 | $17.25M 10-K/A · filed 2019-12-23 | ||||
| 2018-06-30 | $4.17M 10-Q · filed 2019-08-14 | $8.51M derived: sum of 2 quarters · filed 2019-08-14 | $13.54M 10-Q · filed 2019-08-14 | $17.29M derived: sum of 4 quarters · filed 2019-08-14 | ||||
| 2018-03-31 | $4.34M 10-Q · filed 2019-05-14 | $9.36M 10-Q · filed 2019-05-14 | $13.12M derived: sum of 3 quarters · filed 2019-05-14 | $17.89M derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | $5.03M 10-Q · filed 2019-02-14 | $8.78M derived: sum of 2 quarters · filed 2019-02-14 | $13.55M derived: sum of 3 quarters · filed 2019-02-14 | $21.48M derived: sum of 4 quarters · filed 2019-02-14 | ||||
| 2017-09-30 | $3.75M derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-19 | $8.53M derived: sum of 2 quarters · filed 2018-12-19 | $16.45M derived: sum of 3 quarters · filed 2018-12-19 | $21.41M 10-K · filed 2018-12-19 | ||||
| 2017-06-30 | $4.78M 10-Q · filed 2018-08-14 | $5.25M 10-Q · filed 2017-08-09 | $12.70M derived: sum of 2 quarters · filed 2018-08-14 | $17.66M 10-Q · filed 2018-08-14 | $19.08M 10-Q · filed 2017-08-09 | $24.39M derived: sum of 4 quarters · filed 2018-08-14 | ||
| 2017-03-31 | $7.92M 10-Q · filed 2018-05-15 | $8.40M 10-Q · filed 2017-05-10 | $12.88M 10-Q · filed 2018-05-15 | $13.83M 10-Q · filed 2017-05-10 | $19.62M derived: sum of 3 quarters · filed 2018-05-15 | $25.65M derived: sum of 4 quarters · filed 2018-05-15 | ||
| 2016-12-31 | $4.96M 10-Q · filed 2018-02-12 | $5.43M 10-Q · filed 2017-02-09 | $11.69M derived: sum of 2 quarters · filed 2018-02-12 | $17.73M derived: sum of 3 quarters · filed 2018-02-12 | $23.56M derived: sum of 4 quarters · filed 2018-02-12 | |||
| 2016-09-30 | $6.74M 10-K/A · filed 2017-12-11 | $7.22M 10-K · filed 2016-12-15 | $12.77M derived: sum of 2 quarters · filed 2017-12-11 | $18.60M derived: sum of 3 quarters · filed 2017-12-11 | $23.93M 10-K · filed 2017-12-29 | $25.84M 10-K · filed 2016-12-15 | ||
| 2016-06-30 | $6.04M 10-K/A · filed 2017-12-11 | $6.51M 10-Q · filed 2016-08-09 | $11.87M derived: sum of 2 quarters · filed 2017-12-11 | $17.19M 10-Q/A · filed 2017-12-11 | $18.62M 10-Q · filed 2016-08-09 | $24.99M derived: sum of 4 quarters · filed 2017-12-11 | ||
| 2016-03-31 | $5.83M 10-K/A · filed 2017-12-11 | $6.31M 10-Q · filed 2016-05-10 | $11.16M 10-Q/A · filed 2017-12-11 | $12.11M 10-Q · filed 2016-05-10 | $18.95M derived: sum of 3 quarters · filed 2017-12-11 | $27.07M derived: sum of 4 quarters · filed 2017-12-11 | ||
| 2015-12-31 | $5.33M 10-K/A · filed 2017-12-11 | $5.80M 10-Q · filed 2016-02-09 | $13.12M derived: sum of 2 quarters · filed 2017-12-11 | $21.24M derived: sum of 3 quarters · filed 2017-12-11 | $28.72M derived: sum of 4 quarters · filed 2017-12-11 | |||
| 2015-09-30 | $7.80M 10-K/A · filed 2017-12-11 | $8.27M 10-K · filed 2015-12-11 | $15.91M derived: sum of 2 quarters · filed 2017-12-11 | $23.39M derived: sum of 3 quarters · filed 2017-12-11 | $33.05M 10-K/A · filed 2017-12-11 | $34.95M 10-K · filed 2015-12-11 | ||
| 2015-06-30 | $8.11M 10-K/A · filed 2017-12-11 | $8.59M 10-Q · filed 2015-08-07 | $15.59M derived: sum of 2 quarters · filed 2017-12-11 | $26.68M 10-Q · filed 2016-08-09 | $33.83M derived: sum of 4 quarters · filed 2017-12-11 | |||
| 2015-03-31 | $7.48M 10-K/A · filed 2017-12-11 | $7.96M 10-Q · filed 2015-05-08 | $18.09M 10-Q · filed 2016-05-10 | $25.72M derived: sum of 3 quarters · filed 2017-12-11 | $32.63M derived: sum of 4 quarters · filed 2017-12-11 | |||
| 2014-12-31 | $9.66M 10-K/A · filed 2017-12-11 | $10.13M 10-Q · filed 2015-02-06 | $18.24M derived: sum of 2 quarters · filed 2017-12-11 | $25.15M derived: sum of 3 quarters · filed 2017-12-11 | $31.45M derived: sum of 4 quarters · filed 2017-12-11 | |||
| 2014-09-30 | $8.58M 10-K · filed 2015-12-11 | $15.50M derived: sum of 2 quarters · filed 2015-12-11 | $21.79M derived: sum of 3 quarters · filed 2015-12-11 | $25.93M 10-K/A · filed 2017-12-11 | $27.84M 10-K · filed 2014-12-23 | |||
| 2014-06-30 | $6.92M 10-K · filed 2015-12-11 | $13.21M derived: sum of 2 quarters · filed 2015-12-11 | $19.26M 10-Q · filed 2015-08-07 | $24.35M derived: sum of 4 quarters · filed 2015-12-11 | ||||
| 2014-03-31 | $6.29M 10-K · filed 2015-12-11 | $12.34M 10-Q · filed 2015-05-08 | $17.43M derived: sum of 3 quarters · filed 2015-12-11 | $23.06M derived: sum of 4 quarters · filed 2015-12-11 | ||||
| 2013-12-31 | $6.05M 10-K · filed 2015-12-11 | $11.13M derived: sum of 2 quarters · filed 2015-12-11 | $16.76M derived: sum of 3 quarters · filed 2015-12-11 | $21.02M derived: sum of 4 quarters · filed 2015-12-11 | ||||
| 2013-09-30 | $5.09M 10-K · filed 2014-12-23 | $10.71M derived: sum of 2 quarters · filed 2014-12-23 | $14.97M derived: sum of 3 quarters · filed 2014-12-23 | $20.03M 10-K · filed 2015-12-11 | ||||
| 2013-06-30 | $5.63M 10-K · filed 2014-12-23 | $9.88M derived: sum of 2 quarters · filed 2014-12-23 | $14.94M 10-Q · filed 2014-08-08 | $19.37M derived: sum of 4 quarters · filed 2014-12-23 | ||||
| 2013-03-31 | $4.26M 10-K · filed 2014-12-23 | $9.31M 10-Q · filed 2014-05-12 | $13.75M derived: sum of 3 quarters · filed 2014-12-23 | $17.99M derived: sum of 4 quarters · filed 2014-12-23 | ||||
| 2012-12-31 | $5.06M 10-K · filed 2014-12-23 | $9.49M derived: sum of 2 quarters · filed 2014-12-23 | $13.74M derived: sum of 3 quarters · filed 2014-12-23 | $18.11M derived: sum of 4 quarters · filed 2014-12-23 | ||||
| 2012-09-30 | $4.43M 10-K · filed 2013-12-27 | $8.68M derived: sum of 2 quarters · filed 2013-12-27 | $13.05M derived: sum of 3 quarters · filed 2013-12-27 | $17.50M 10-K · filed 2014-12-23 | ||||
| 2012-06-30 | $4.25M 10-K · filed 2013-12-27 | $8.62M derived: sum of 2 quarters · filed 2013-12-27 | $13.07M 10-Q · filed 2013-08-09 | $16.96M derived: sum of 4 quarters · filed 2013-12-27 | ||||
| 2012-03-31 | $4.37M 10-K · filed 2013-12-27 | $8.82M 10-Q · filed 2013-05-10 | $12.72M derived: sum of 3 quarters · filed 2013-12-27 | $17.64M derived: sum of 4 quarters · filed 2013-12-27 | ||||
| 2011-12-31 | $4.45M 10-K · filed 2013-12-27 | $8.35M derived: sum of 2 quarters · filed 2013-12-27 | $13.27M derived: sum of 3 quarters · filed 2013-12-27 | $18.41M derived: sum of 4 quarters · filed 2013-12-27 | ||||
| 2011-09-30 | $3.90M 10-K · filed 2012-12-14 | $8.82M derived: sum of 2 quarters · filed 2012-12-14 | $13.96M derived: sum of 3 quarters · filed 2012-12-14 | $18.94M 10-K · filed 2013-12-27 | ||||
| 2011-06-30 | $4.92M 10-K · filed 2012-12-14 | $10.06M derived: sum of 2 quarters · filed 2012-12-14 | $15.04M 10-Q · filed 2012-08-09 | $20.70M derived: sum of 4 quarters · filed 2012-12-14 | ||||
| 2011-03-31 | $5.14M 10-K · filed 2012-12-14 | $10.12M 10-Q · filed 2012-05-10 | $15.77M derived: sum of 3 quarters · filed 2012-12-14 | $19.20M derived: sum of 4 quarters · filed 2012-12-14 | ||||
| 2010-12-31 | $4.98M 10-K · filed 2012-12-14 | $10.63M derived: sum of 2 quarters · filed 2012-12-14 | $14.06M derived: sum of 3 quarters · filed 2012-12-14 | |||||
| 2010-09-30 | $5.65M derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-14 | $9.08M derived: sum of 2 quarters · filed 2012-12-14 | $18.71M 10-K · filed 2012-12-14 | |||||
| 2010-06-30 | $3.42M 10-Q · filed 2011-08-09 | $13.06M 10-Q · filed 2011-08-09 | ||||||
| 2009-09-30 | $12.10M 10-K · filed 2011-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |